Provided by Tiger Trade Technology Pte. Ltd.

Goldman Sachs Future Health Care Equity ETF

37.25
0.0000
Volume:9
Turnover:333.15
Market Cap:19.56M
PE:- -
High:37.25
Open:37.25
Low:37.25
Close:37.25
52wk High:38.66
52wk Low:31.32
Shares:525.00K
Float Shares:525.00K
Volume Ratio:0.04
T/O Rate:0.00%
Dividend:0.11
Dividend Rate:0.31%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Johnson & Johnson receives CE Marking for ACUVUE OASYS MAX

TIPRANKS
·
Sep 10

Johnson & Johnson Receives Ce Marking for Acuvue Oasys Max Reusable Contact Lenses

THOMSON REUTERS
·
Sep 10

CAMP4 Therapeutics Receives Authorization in the United Kingdom for Phase 1/2 Human Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder

GlobeNewswire
·
Sep 10

HSBC Adjusts Price Target on Eli Lilly and Co. to $940 From $850, Keeps Reduce Rating

MT Newswires Live
·
Sep 10

Tellgen's Subsidiary Device Registration Application Accepted by Regulator

Stock News
·
Sep 10

LIFETECH SCI's LantvalTM Aortic Valve Replacement System Clears NMPA Fast-Track Review for Innovative Devices

Stock News
·
Sep 10

'Cut Points' for 2027 Medicare Advantage Plans Look Neutral to Positive, Analysts Say

Reuters
·
Sep 10

Sector Update: Healthcare

MT Newswires Live
·
Sep 10

Why Is UnitedHealth Stock (UNH) Down on Wednesday, 9/9/2026?

TIPRANKS
·
Sep 10

Merck Price Target Raised to $161.00/Share from $127.00 by Leerink Partners

Dow Jones
·
Sep 10

Top Midday Stories: Meta Launches Muse Personal AI Agent; Dow Said to Consider Exiting $20 Billion Chemicals JV With Saudi Aramco

MT Newswires Live
·
Sep 09

UnitedHealth Falls; Cites Pressure in Commercial Business

Reuters
·
Sep 09

Tyra Biosciences Stock Plunges 22% as Bladder Cancer Pill Fails to Impress

Dow Jones
·
Sep 09

UnitedHealth Shares Down 5.2%

THOMSON REUTERS
·
Sep 09

Unitedhealth Group Inc Stock (UNH) Opened Down by 3.79% on Sep 9: Facts Behind the Movement

TradingKey
·
Sep 09

UnitedHealth, Alphabet Inc. Cl a Share Losses Lead Dow's 350-Point Drop

Dow Jones
·
Sep 09

UBS Adjusts Guardant Health Price Target to $225 From $175, Maintains Buy Rating

MT Newswires Live
·
Sep 09

IMUNON Announces Full Agenda and Speaker Lineup Ahead of 2026 R&D Day Highlighting IMNN-001 Clinical Progress

GlobeNewswire
·
Sep 09

ProQR Therapeutics doses first participant in AX-0811 clinical trial

TIPRANKS
·
Sep 09

Bayer initiates Phase II study of BAY 3670549 in patients with AFib

TIPRANKS
·
Sep 09